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ABSTRACT 
Diabetes mellitus is a chronic illness effecting approximately 20.8 million individuals in the 
United States.  Minorities are adversely affected, with age-adjusted prevalence 1.7 times higher in 
African Americans than Caucasians.  Type 2 diabetes is significantly affected by behavioral and 
environmental risk factors, including the presence of co-occurring diseases (i.e., hypertension, 
hyperlipidemia), obesity, age, and lack of physical activity, and each of these risk factors is more 
prevalent among African Americans. The treatment of diabetes is largely self-managed, with patients 
and their families handling 95% of their own care.  Adherence to the multi-component diabetic 
treatment regimen requires daily care, often occurring in more than one environment. While many 
studies have attempted to address the impact of social support on the self-management behavior of 
diabetics, few have tried to assess both intra-individual and environmental influences of support on the 
adherence.  There is a paucity of research concerning the diabetic self-care treatment regimen and 
social support in an African American population, or addressing the disproportionate effect of 
environmental influences on African Americans.  The current study sought to address this gap in the 
literature by using the Chronic Illness Resources Survey, a measure of multilevel support resources, to 
assess environmental influences of social support on African American patients’ adherence to self-
management behaviors.  The current study also sought to address common methodological concerns, 
including the addition of glycemic control (HbA1c) as an outcome measure and control for social 
desirability.  
1 
REVIEW OF LITERATURE 
Diabetes Mellitus 
Diabetes mellitus is a group of metabolic disease symptoms characterized by hyperglycemia 
resulting from defects in insulin secretion, insulin action, or both (Expert Committee on the Diagnosis 
and Classification of Diabetes Mellitus, 2003). Diabetes and diabetes-related complications account for 
significant mortality and morbidity annually in the United States.  Approximately 20.8 million 
individuals (nearly 7% of the population) in the United States have diabetes. An estimated 14.6 million 
have been diagnosed with diabetes; unfortunately, 6.2 million people (or nearly one-third) are unaware 
that they have the disease (American Diabetes Association, 2006e; Cowie et al., 2006).  Diabetes was 
the sixth leading cause of death listed on U.S. death certificates in 2002. Yet diabetes is likely to be 
underreported as a cause of death, with a recent study demonstrating that death certificates 
underestimate the prevalence of diabetes (American Diabetes Association, 2006e; McEwen et al., 
2006). The direct (i.e., medical care and services) and indirect (i.e., short-term and permanent 
disability and premature death) costs of diabetes on the public and private health sector constitute a 
tremendous burden on society.  One out of every ten health care dollars spent in the United States is 
spent on diabetes and its complications.  The direct costs of diabetes are estimated to be near $92 
billion annually, nearly 11% of the U.S. health care expenditure (American Diabetes Association, 
2006c).  Finally, diabetes-related hospitalizations totaled 16.9 million days, and outpatient visits to 
treat persons with diabetes totaled 62.6 million in 2002 (American Diabetes Association, 2006c).  
Diabetes is divided into three primary classifications: type 1 (formerly insulin-dependent diabetes 
mellitus), type 2 (formerly non-insulin dependent diabetes mellitus), and diabetes associated with a 
specific medical condition (e.g., pregnancy). Type 1 diabetes is characterized by the absolute 
deficiency of endogenous insulin secretion. The onset of type 1 diabetes is usually abrupt, with marked 
polyuria, polydipsia, polyphagia, weight loss, and fatigue. Type 1 diabetes can occur at any age, 
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however, it occurs most commonly during the middle of the first decade of life and during adolescence 
(Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003). 
The cause of type 2 diabetes is a combination of resistance to insulin action and an inadequate 
compensatory insulin response. Unlike patients with type 1 diabetes, those with type 2 diabetes 
mellitus have some endogenous insulin secretion (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003). In type 2 diabetes, patients may fall within a range of 
impaired glucose tolerance, thus, the clinical presentation and disease course of type 2 diabetes varies 
greatly between patients (American Diabetes Association, 2006d). This classification of diabetes 
frequently goes undiagnosed because hyperglycemia develops gradually and, at earlier stages, is often 
not severe enough for the patient to notice symptoms (Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus, 2003; Harris, 1989). Type 2 diabetes can occur at any age, with the 
majority of patients being diagnosed after age 40. However, clinically-based reports and regional 
studies suggest that type 2 diabetes is being diagnosed more frequently in children and adolescents, 
particularly in minority populations (American Diabetes Association, 2000, 2006e).  The majority of 
patients with type 2 diabetes are obese, which further contributes to insulin resistance (Cox & Gonder-
Frederick, 1992; Lillioja et al., 1985; Virtanen et al., 2005). 
Behavioral and environmental factors appear to make a significant contribution to the 
development of type 2 diabetes. The risk of developing type 2 diabetes increases with age, obesity, and 
lack of physical activity (Harris, 1998; Sullivan, Morrato, Ghushchyan, Wyatt, & Hill, 2005; Zimmet, 
1992). It occurs more frequently in women with a history of gestational diabetes and in individuals 
with hyperlipidemia or hypertension (Expert Committee on the Diagnosis and Classification of 
Diabetes Mellitus, 2003). With the exception of age, these environmental and behavioral risk factors 
are more prevalent among minorities, particularly African Americans (Harris, 1998; Miller et al., 
2004b; Shai et al., 2006). 
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Components of Diabetes Self-Care Treatment 
As a result of its major impact on public health and health care expenditures, diabetes treatment 
has been a major goal of nationwide disease management programs, and much attention has been given 
to the dissemination of treatment guidelines and specific components of treatment.  The goals of 
diabetes treatment are good metabolic control, minimization of complications due to diabetes, control 
of co-occurring diseases (i.e, hypertension, hyperlipidemia), and good quality of life (American 
Diabetes Association, 2006d). Treatment for diabetes mellitus involves restoring blood glucose to or 
near normal levels in all patients. The American Diabetes Association (ADA) recommends a treatment 
target for diabetes that includes a glycosylated hemoglobin (HbA1c) level < 7% and a fasting plasma 
glucose (FPG) of < 120 mg/dl. Treatment for type 2 diabetes is designed to maximize the effect of 
endogenous insulin by decreasing insulin resistance.  
Significant patient involvement is necessary to achieve treatment goals, and diabetes care is 
almost always carried out by patients and their families (Toljamo & Hentinen, 2001). To maintain 
adequate glycemic control, patients typically follow a self-care regimen involving frequent self-
monitoring of blood glucose (SMBG), dietary modifications, exercise, education, and medication 
administration. In addition, a majority of diabetes self-care treatment regimens include activities 
toward the goal of reducing diabetes mellitus-related complications (e.g., foot and eye care) and 
behaviors targeting the reduction of cardiovascular risk factors (e.g., high fat diet, sedentary lifestyle, 
smoking) (American Diabetes Association, 2006d).   
Dietary Modifications and Physical Activity. Lifestyle modifications in the form of dietary 
change and the initiation of physical activity are essential components of diabetes self-management, 
and are often a first-line therapy for persons newly diagnosed with type 2 diabetes (UKPDS, 1995). 
Diets with moderate caloric restriction (e.g., 250-500 calories less than daily intake), a reduction in 
saturated fats, increase in fiber and vegetable consumption, and an increase in physical activity have 
been recommended for patients with diabetes (American Diabetes Association, 2006b; Franz, 1997). A 
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specific aim of dietary modification is a reduction in body weight, because weight loss through proper 
diet and exercise results in improved glycemic control and reductions in cardiovascular risk factors 
(e.g., blood pressure, plasma lipid levels) and overall mortality (Wing et al., 2001; Wing, Venditti, 
Jakicic, Polley, & Lang, 1998).  Several studies have shown that specific dietary modifications, such as 
the increased consumption of whole grains and reduced saturated fat intake, along with weight loss and 
increased physical activity, may delay or prevent the onset of type 2 diabetes in high risk patients (van 
Dam, 2003; Wing et al., 2001). 
Self-monitoring of Blood Glucose. Another important component to diabetes self-
management is the self-monitoring of blood glucose (SMBG) levels. Glycemic stability can be 
checked using a lancet and a calibrated blood glucose monitor or by regular urine checks (American 
Diabetes Association, 2006a). New self-calibrating, continuous blood-glucose monitoring systems that 
avoid regular blood sampling from the fingertip are currently being tested for use in diabetes self-
management (Kilo et al., 2006).  Regardless of method, if used properly, SMBG gives an acceptably 
accurate reflection of immediate plasma glucose levels. Results of SMBG are used to assess the 
efficacy of therapy as well as provide information regarding necessary adjustments to nutritional 
therapy and medication. The ADA (American Diabetes Association, 2006a) recommends daily blood 
glucose monitoring by patients on insulin therapy to prevent hypoglycemia or other related 
complications. Study results vary, but in general, the evidence supports a positive effect of regular 
SMBG for improving glycemia, particularly in individuals treated with insulin. While frequency of 
SMBG may range from 1 to 4 checks per day, the clinical recommendation is for regular monitoring 
with frequency depending on disease severity, treatment plan, instability of glycemia, and the overall 
functioning of the patient (Saudek, Derr, & Kalyani, 2006). 
In addition to SMBG, the measurement of HbA1c, a target indicator suggested by the ADA, 
provides a stable and longer-term measurement of glycemic status.  HbA1c measures reflect a time-
weighted mean over the previous 120 days, and most accurately reflect the previous 3-4 months of 
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metabolic control (Saudek et al., 2006). The ADA recommends routine HbA1c testing two times per 
year in patients maintaining adequate control, and more frequently among patients who have not 
maintained control or who have changed their therapeutic regimen (American Diabetes Association, 
2006d; Saudek et al., 2006). The main value of HbA1c is its use as a predictor of diabetes 
complications and the proven effect of improved control of HbA1c on complication risk (Saudek et al., 
2006). A reasonable target value for HbA1c is less than 7%, and the ADA recommends that therapy be 
reevaluated when HbA1c exceeds 8%. 
Medication. While modifications to diet and exercise are an initial and conservative treatment 
for type 2 diabetes, many patients require pharmacologic intervention to maintain glycemic control 
(Riddle, 1999).  The medications for people with type 2 diabetes are classified into those that increase 
endogenous insulin secretion, those that enhance the effectiveness of insulin, or those that improve the 
sensitivity of peripheral tissues to insulin.  Medications come in the form of pills or injectable insulin, 
although inhalable insulin and newer synthetic hormones (e.g., pramlintide) are currently being tested 
for approval in the United States. 
   Diabetes self-management is obviously a multi-component regimen, with patients possessing 
a great deal of influence on their own glycemic control, overall health, and quality of life. Indeed, lack 
of participation in a variety of self-care behaviors contributes to poor glucose control, leading to 
greater incidence of complications, morbidity, and mortality (UKPDS, 1995, 1998a, 1998b).  While 
other components are also important to the reduction in diabetes-related complications (i.e., foot and 
eye care, smoking cessation), the current study focused on the self-management behaviors described 
above (i.e., diet, physical activity, SMBG, and medication), which have been shown to be most directly 
related to glycemic control (UKPDS, 1995, 1998a, 1998b). 
Adherence to Diabetes Self-Care Regimen  
To achieve the therapeutic goals of diabetes management, adherence to self-care is crucial 
because most of diabetes care is carried out by patients and their families (Toljamo & Hentinen, 2001). 
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Self-care management is necessary for improved physical functioning and reduction in diabetes-related 
complications, and day-to-day lifestyle modifications as described above are needed to optimize 
glycemic control.  While medical management is a component of almost all treatment plans, patients 
may handle up to 95% of their own care of this chronic disease (Anderson et al., 1993). Therefore, 
promoting adherence to active self-care is a major goal in diabetes education. Self-care in diabetes may 
involve complex changes in basic behaviors or adherence to complicated, multi-component regimens 
(Day, Bodmer, & Dunn, 1996). Active self-care often consists of performing home blood glucose 
monitoring and adjusting other treatment components to compensate for results, variation of nutrition 
in response to daily needs, insulin dose adjustments to meet actual needs, and regular exercise (de 
Weerdt, Visser, Kok, & van der Veen, 1990). Furthermore, patients must be responsible for making 
necessary adjustments to their medication and dietary needs in the event of illness. It is inevitable that 
successful self-care and optimal balance require motivation, support, and encouragement by family, 
friends, and health care professionals (Day et al., 1996). 
Assessment of Adherence. The assessment of adherence to diabetes self-care is often difficult, 
whether due to changing operational definitions, lack of patient behavior observations, or social 
desirability bias in patients’ reporting of their self-care behaviors (Hentinen & Kyngas, 1992).  In past 
decades, the conceptualization of adherence has shifted from a focus on patient’s personality features, 
attributing low adherence to a maladaptive personality style, to the procedural delivery of medical 
treatment and the patient’s beliefs and commitment to engaging in health-related behaviors (Glasgow 
& Anderson, 1999). By the nature of self-care diabetes treatment, such procedural delivery is often not 
observable by health care professionals.  For example, patients who do not record the timing of their 
insulin administration or the results of SMBG, regardless of their participation in these behaviors, 
cannot be adequately assessed for treatment adherence.  Furthermore, observations of the outcomes of 
adherence (e.g., adequate glycemic control) are often difficult to obtain in the form of blood or urine 
samples (Hentinen & Kyngas, 1992).  One of the most reliable measures of a patient’s stability of 
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glycemic control, HbA1c, is typically recommended only twice per year.  Lastly, patients with low 
adherence may report an excessively positive review of their own behaviors (Gordis, 1981). 
Previous findings concerning self-management and adherence to self-care among patients with 
diabetes vary greatly. A literature review by Hentinen (Hentinen & Kyngas, 1992) showed that 
adherence rates may range from 30 to 80%, depending on the interventions and research methods used 
in the studies. In general, patients with diabetes vary in their adherence to individual components of 
treatment.  Some research has questioned whether response to treatment is a reliable criterion for 
adherence to regimen, due to the multi-component nature of treatment and other factors (Hentinen & 
Kyngas, 1992).  Adherence to one therapeutic recommendation does not indicate adherence to others 
(Botelho, 2002), and each treatment component is associated with unique barriers to adherence.   
Barriers to Adherence. The Diabetes Prevention Program, an NIH-sponsored, multi-site, 
randomized controlled trial comparing lifestyle modification intervention and pharmacologic treatment 
of diabetes, found that modification of lifestyle features (i.e., eating habits and physical activity) were 
more effective than medication in reducing the incidence of type 2 diabetes (Knowler et al., 2002).  
According to some studies, patients with diabetes have more difficulties in adhering to a suitable diet 
and exercise regimen than to insulin medication (Ary, Toobert, Wilson, & Glasgow, 1986; Glasgow, 
Hampson, Strycker, & Ruggiero, 1997; Hentinen & Kyngas, 1992; Vijan et al., 2005). While there is 
some evidence to show a positive linear relationship for knowledge of the diabetes-specific diet and 
adherence to that diet (Watson & DuFord, 1992), knowledge alone does not constitute the major health 
dilemma of dietary change. In a study by Ary and colleagues (Ary et al., 1986), subjects reported 
environmental factors as the most challenging to their dietary adherence.  Open-ended questions 
revealed that the most common reasons for dietary nonadherence were the situational factors of eating 
out at restaurants and inappropriate food offers from others (Ary et al., 1986). 
In contrast, the findings concerning self-monitoring of blood glucose are controversial. Some 
researchers (Peveler, Davies, Mayou, Fairburn, & Mann, 1993) have demonstrated that patients with 
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diabetes control their blood glucose regularly.  Others have reported regular self-monitoring of blood 
glucose to be uncommon among patients with diabetes (Evans et al., 1999; Richmond, 1993). Evans 
and colleagues (Evans et al., 1999) calculated adherence to SMBG via dispensing and recording six-
month use of lancets for blood glucose monitors, whereas Richmond (Richmond, 1993) administered 
self-report questionnaires. 
Social Support and Diabetes 
Social support is important for patients with chronic disease, particularly those with diseases 
requiring multi-component therapy, as with diabetes mellitus. As noted above, patients with diabetes 
may self-manage up to 95% of their own care (Anderson et al., 1993). Successful adherence to the 
diabetes treatment regimen translates to daily care, often occurring in more than one environment and 
with the knowledge (and possibly intervention) of individuals other than the patient alone: immediate 
family members, friends, co-workers, health care staff, and more.  
Models of Social Support. As a concept and a construct, social support has been used 
extensively both in theoretical and research literature since its introduction about thirty years ago; 
however, operational definitions are generally not consistent.  Other constructs have been subsumed 
under the general concept of social support without clear delineation (Hupcey, 1998).  Specifically, 
‘social networks’ have been included in several operational definitions of social support, although this 
is generally now considered an allied concept (Hupcey, 1998).  Social networks refers more to the 
structure, number, and composition of an individual’s interpersonal ties rather than the quality or type 
of assistance being offered by the parts of the network (Vrabec, 1997). 
Conceptual reviews of social support by Hupcey (Hupcey, 1998) and Vrabec (Vrabec, 1997) 
refer to three aspects common to past theoretical and operational definitions of social support found in 
literature: (a) structural aspects of the support networks, (b) functional types of assistance available, 
perceived, or actually received, and (c) the nature of the support. Functional support is one of the most 
common definitions applied to the measurement of social support, and its dimensions include 
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emotional, instrumental, informational, companionship, and validational support (Wills & Shinar, 
2000). The nature of the support reflects a patient’s satisfaction with the support received, the degree 
of reciprocity between network components and the individual, and whether network interaction is 
perceived as present, helpful, and/or conflicting (Hupcey, 1998). 
Inconsistencies and inadequacies in the definitions of social support are numerous, and many 
definitions are not abstract enough to include all instances in which social support may occur (Hupcey, 
1998).  Existing research on support and health outcomes has several limitations related to these 
inadequacies of the social support construct (Glasgow, Strycker, Toobert, & Eakin, 2000; Hupcey, 
1998; Martin & Brantley, 2004).  For example, most studies have used only a single measure of 
support or a single support source (e.g., spouse or co-worker), or failed to relate support measures to 
conceptual models.  One prolific scientist in this area points to researchers using a limited range of 
health outcomes and failure to control for potential confounding covariates (such as demographics and 
social desirability bias) as additional limitations within the social support and disease management 
literature (Glasgow et al., 2000). 
Adherence and Social Support. Although social support and adherence to self-care medical 
regimens (e.g., pregnancy, epilepsy, HIV) have been studied (Cameron, Wells, & Hobfoll, 1996; C. 
DiIorio, Hennessy, & Manteuffel, 1996; Colleen DiIorio et al., 2006; Vincke & Bolton, 2002), less 
attention has been given to the relationship between adherence to self-care and perceived social 
support or to the need for social support among patients with diabetes.  Some studies of people with 
diabetes claim that social support can actually promote adherence to self-care, and through adherence 
patients may achieve better metabolic control (Tillotson & Smith, 1996; Wang & Fenske, 1996). 
Shafer (Schafer, McCaul, & Glasgow, 1986) reported that greater levels of non-supportive family 
behavior were related to lower regimen adherence. Contrary to these findings, Murphy and colleagues 
(Murphy, Williamson, & Nease, 1994) found that social support from a family member did not result 
in better metabolic control.  The conflicting research literature may be due to inconsistencies in 
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operational definitions of social support applied, or a limited view of the type or functions of support 
investigated.  Another explanation is that although social support promotes adherence to self-care, 
adherence to the self-care regimen does not automatically lead to better metabolic control (Toljamo & 
Hentinen, 2001).  
Environmental Influences. Diabetes management and regimen-related behaviors are 
influenced not only by intra-individual factors but also by the system that surrounds the individual.  
The Standards for Medical Care in Diabetes purports that the management plan for patients with 
diabetes should be individualized based not on the patient, but on the patient and his or her 
environment (American Diabetes Association, 2006d). Recently, the community context of individuals 
with diabetes has received much attention, partly because of the disparity in health status between 
ethnic and Caucasian groups in the United States (Ruggiero et al., 1997). Another more recent 
development is the research literature is an emphasis away from physician-only guidance and in the 
direction of the multidisciplinary health care team approach towards disease management. Many 
studies advocate the application of intensive intervention using a team approach towards optimizing 
patient adherence and, as an expected outcome, balanced glycemic control (Knowler et al., 2002; 
Koenigsberg, Bartlett, & Cramer, 2004).  Such health care teams are in practice, with physician, 
nurses, dieticians, diabetes educators, and sometimes psychologists being part of the diabetes health 
care team.  With such evidence for the importance of a wider system of care for the patient with 
diabetes, it is imperative to understand environmental influences in addition to traditional social 
support. 
The ecologic or biopyschosocial model of disease management is one that extends the 
boundaries of traditional social support to more adequately explain the paradigm of disease and 
behavior as a function of several factors, including biologic, psychosocial, developmental, 
sociocultural, and ecologic factors (Auslander & Corn, 1996).  Three social contexts, (a) the family, (b) 
health care system, and (c) the community, are believed to have considerable impact on individuals 
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with diabetes (Auslander & Corn, 1996). These contexts are in addition to those traditional 
implications of the biomedical model, which emphasizes individual influences on diabetes 
management (Engel, 1977). 
This model, further developed from a purely theoretical definition toward research initiatives 
by Glasgow and colleagues (Glasgow & Anderson, 1999; Glasgow et al., 2000), attempts to address 
disease self-management from a multi-level “pyramid” model of social-environmental support 
(Glasgow et al., 2000).  Similar to more traditional social support definitions, this ecological model 
includes support from both family and friends.  It also incorporates the theory that chronically ill 
patients tend to be influenced additionally by distal sources of support (Hupcey, 2001), including 
workplace, media, public policy, community, and neighborhood (Glasgow et al., 2000).  The sources 
of support are further divided into formal (or institutional) and informal (or interpersonal) networks.  
Institutional sources include media, public policy, work environment, and an individual’s 
multidisciplinary health care team.  Interpersonal sources include the community and regional 
environment, neighborhood, family, and friends.  An advantage of Glasgow’s application of the 
ecological model is an attempt to capture comparative and combined influences of different levels of 
support and the effects of more passive interventions, including public policy and environmental 
factors, in addition to more traditional active support behaviors (Glasgow et al., 2000). 
Another important advantage of the ecological model is its implications for a better 
understanding of the environmental factors that may contribute to racial disparity in chronic illness, 
particularly diabetes.  Both the National Diabetes Data Group (NDDG) and the National Health and 
Nutrition Examination Survey (NHANES) show a higher incidence of diabetes in African Americans 
than Caucasians (Harris, Hadden, Knowler, & Bennett, 1987; Roseman, 1985). In 1985, NDDG 
showed that 1 in 4 African American women over the age of 55 had diabetes (Roseman, 1985), and a 
2004 published study of diabetes-related health disparities demonstrated the age-adjusted prevalence of 
the illness is 1.7 times higher in African Americans than Caucasians (Miller et al., 2004a).  
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Environmental and community factors are, in some part, believed to contribute to poorer health 
status and higher diabetes prevalence within minority communities, particularly African Americans. 
Generally lower SES levels among minority groups contributes to this disparity, with fewer financial 
and educational resources, less emphasis on preventive care, and often lower quality of medical 
services available to this population (Auslander & Corn, 1996). However, low SES levels is not the 
sole contributor, with evidence suggesting that environmental factors associated with poverty may 
have a negative impact on health status (Kaplan, 1994).  Community factors such as overcrowding, 
pollution, neighborhood crime, inadequate housing, and unhealthy low-wage work environments may 
all contribute to overall poorer health (Auslander & Corn, 1996).   
Some research evidence suggests that African American patients with diabetes may be 
disproportionately affected by some environmental contexts.  There is evidence for African Americans 
to rely more than Caucasian individuals in informal social networks in the management of their 
diabetes (Ford, Tilley, & McDonald, 1998).  Within the context of the health care system, one 
published study demonstrates that for African American patients, relative to Caucasian patients, 
physicians’ assessments of diabetes management are significantly farther away from patients' self-
assessments (Lutfey & Ketcham, 2005).  Lastly, the published data of Ford and colleagues showed that 
social support was significantly associated with improved diabetes management among African 
Americans (Ford et al., 1998). 
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SUMMARY AND STUDY RATIONALE 
The current study applied a cross-sectional design to assess the environmental influences on 
social support and adherence in a sample of low-income, African American patients with diabetes. 
Given the increased prevalence among minorities and the relative contribution of environmental and 
behavioral factors in the onset and exacerbation of type 2 diabetes, the present study focused only on 
individuals with this classification of the disease. The study focused on African American participants 
(1) because of the paucity of research concerning the diabetes self-care treatment regimen and social 
support in this population; (2) African American patients have also been shown to be 
disproportionately affected by various environmental influences; (3) the Chronic Illness Resources 
Survey, a measure of the multi-level model of socio-environmental support, was validated in a 96% 
Causcasian sample (Glasgow et al., 2000), and no published reports have administered this 
questionnaire in a minority sample.     
The current study sought to address some of the methodological concerns common to this 
research area.  As Glasgow and colleagues (Glasgow et al., 1997; Glasgow et al., 2000; Glasgow, 
Toobert, Barrera, & Strycker, 2005) point to a limited use of outcome variables related to self-care, 
outcome measures in this study included both measures of self-reported adherence and glycemic 
control.  Self-reported adherence was measured using the Summary of Diabetes Self-Care Activities 
measure, which is the most widely used self-report instrument for measuring diabetes self-management 
in adults (Toobert, Hampson, & Glasgow, 2000).  Glycemic control was obtained in the form of 
glycosylated hemoglobin (i.e., HbA1c) measures taken from medical chart reviews. Lastly, as self-
reported adherence to components of the diabetes self-care regimen may be confounded by socially 
desirable responding (Gordis, 1981), the current study also measured and statistically controlled for 
social desirability.   
Given the findings and limitations of previous research, the primary aim of this study was to 
determine whether perceived support from various environmental and community sources is positively 
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related with adherence to the diabetes self-care therapeutic regimen and glycemic control among low 
income African Americans.  Secondary aims included understanding the relative contributions of the 
ecological and traditional models of social support to the prediction of adherence behaviors and 
glycemic control, and the validation of the Chronic Illness Resources Survey in this population.  In the 
current study, the following research questions and hypotheses were addressed.  
Primary Hypotheses 
The primary research questions of the current project were: How is self-reported support from 
environmental social resources for illness-related behaviors related to adherence to self-management 
behaviors in patients with diabetes? How is self-reported support from environmental social resources 
for illness-related behaviors related to glycemic control in patients with diabetes? The ecological 
model of social support has not previously been measured in the low SES, African American 
population, but research evidence suggests that African Americans, although disproportionately 
affected by some environmental contexts, demonstrate improved  diabetes management associated 
with their level of social support (Ford et al., 1998). Research also suggests that different components 
of diabetes self-management are independent (Johnson, 1992; Toljamo & Hentinen, 2001; Toobert et 
al., 2000), as adherence to one therapeutic recommendation does not indicate adherence to others 
(Botelho, 2002), and each treatment component is associated with unique barriers to adherence.  Thus, 
the diabetes self-management behaviors were investigated separately from each other and from 
glycemic control.  Therefore, the primary research questions of this study were modified into two 
primary hypotheses: 
1. Higher levels of self-reported social resources for illness-related behaviors will be related to 
greater self-reported adherence to diabetes self-care treatment behaviors (i.e., diet, physical 
activity, blood glucose testing, medication-taking).  
2. Higher levels of self-reported social resources for illness-related behaviors will be related to 
better glycemic control (i.e., glycosylated hemoglobin). 
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Secondary Hypotheses 
The third research question posed by this project was: Does the ecological model provide 
additional information to the understanding of how the traditional model of social support predicts 
patients’ adherence to diabetes self-management behaviors and/or glycemic control? While the 
ecological model is similar to traditional social support definitions, it also incorporates more distal 
sources of support (Hupcey, 2001), and attempts to capture both comparative and combined influences 
of different levels of support (Glasgow et al., 2000).  Thus, a secondary hypothesis of this study stated 
that the ecological model, as measured by the CIRS subscales, would contribute additional variance 
beyond that contributed by a more traditional model of social support, as measured by the ISEL-12: 
3. The ecological model of social resources will add additional variance, beyond the variance 
explained a traditional model of social support, to the prediction of patients’ adherence to self-
management behaviors and glycemic control. 
A final research question presented by the current study is: Can the Chronic Illness Resources 
Survey (CIRS) be used as a reliable and valid measure of multilevel environmental influences of social 
support for illness-related behaviors in an African American, low SES population?  This question was 
indeed a secondary aim of the project, as evidence for the impact of environmental risk factors (Harris, 
1998; Miller et al., 2004b; Shai et al., 2006) and environmental resources on diabetes and chronic 
illness prevalence is already reported in the research literature for minorities, particularly African 
Americans (Auslander & Corn, 1996; Kaplan, 1994).  The current project sought to fill the gap in the 
literature by reporting reliability coefficients and internal validity analysis for the CIRS in this 
population, and the final hypothesis was: 
4. The Chronic Illness Resources Survey (CIRS) will demonstrate comparable reliability and 
internal validity in the low income, African American sample to its previous application in a 
primarily Caucasian sample. 
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METHODS 
 
Participants 
One hundred fifty-nine participants were recruited from the waiting rooms of medicine and 
primary care clinics at Earl K. Long Medical Center. Earl K. Long is a teaching hospital affiliated with 
the Louisiana State University Health Sciences Center, and it serves a predominantly low-income, 
uninsured population. 
The inclusion criteria required that participants be African American outpatients with 
previously diagnosed type 2 diabetes mellitus attending routine medical appointments.  African 
American participants were selected due to the paucity of research concerning diabetes self-care 
treatment regimen and social support in this population. Patients were excluded from the study if they 
were not African American (as classified in the medical chart), not current patients at Earl K. Long 
Medical Center,  under 18 years of age, or could not orally comprehend material at a ninth grade level 
as indicated by their performance on the Woodcock Johnson Oral Comprehension subtest.  They were 
also excluded if they carried a current diagnosis of a major mental illness (schizophrenia, bipolar 
disorder) or mental retardation as identified by medical chart review. 
One hundred ninety-six patients were approached for participation (see Figure 1). Of these 
patients, 30 indicated that they did not want to consent to participate.  Reasons for refusal included: not 
wanting the medical chart to be reviewed (5), not feeling well enough to answer questions (3), not 
having the time to answer questions (13), not wanting to participate with no other reason given (8), or 
concern about emotional risk of answering survey questions (1). 
Seven patients were excluded from participation because they reported that they were not Earl 
K. Long patients (4), had diabetes mellitus type 1 (2), or were diagnosed as having pre-diabetes and 
not diabetes mellitus type 2 (1). No people were excluded for not being listed as African American in 
their medical chart, for not meeting the age or oral comprehension requirements, or for having a 
current diagnosis of major mental illness. 
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Figure 1. Participant flow through study 
Measures 
Demographic Questionnaire. A demographic questionnaire was administered to obtain the 
following information: hospital number, date of birth, BMI data, marital status, highest level of 
education completed, employment status, monthly household income, number of months since type 2 
diabetes mellitus diagnosis, diabetes medications, and other chronic illness diagnoses (see Appendix 
A).  
Chronic Illness Resources Survey (CIRS).  The CIRS (Glasgow et al., 2000) is a 64-item 
scale for assessing multilevel environmental influences of social support, predicting successful 
behavior change, and detecting social-ecological intervention effects.  This measure provides a profile 
of an individual’s support for disease management-related behaviors, ranging from proximal support 
(e.g., family and friends) to more distal factors (e.g., neighborhood or community) (see Appendix B).  
Respondents rate the extent to which each of the items was used over the past 3 months on a 1 (not at 
all) to 5 (a great deal) Likert scale. The CIRS has a total score and seven source subscales: personal, 
Assessed for eligibility in waiting room (n = 196) 
Excluded (n = 37) 
     Refused to participate (n = 30) 
     Not meeting inclusion criteria (n = 7) 
Consented to participate in study 
and medical chart review (n =159) 
Analyzed (n = 156) 
 
Excluded from analysis (n = 3) 
     Consented but did not answer any   
     questionnaires (n = 3) 
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family and friends, physician/health care team, neighborhood/community, organizations, work, media 
and policy.  The subscales have demonstrated good internal consistency and stability, with test-retest 
correlations ranging from 0.55 to 0.66 for subscales and 0.70 for the total score.  Internal consistency 
for the overall scale is α = 0.82.  Previous research with primarily Caucasian populations has 
demonstrated that social desirability is not correlated with the CIRS. 
Summary of Diabetes Self-Care Activities Measure (SDSCA). The SDSCA measure 
(Toobert et al., 2000) is an 11-item self-report questionnaire of diabetes self management that includes 
items assessing the following aspects of the diabetes regimen: general diet, specific diet, exercise, 
blood glucose testing, and medication-taking (see Appendix C). The SDSCA is the most widely used 
self-report instrument for measuring diabetes self-management in adults.  Items assessing adherence to 
specific behaviors are scored based on reported levels of self-care over a consecutive 7-day period. 
Items assessing knowledge of self-care recommendations are scored based on which treatment 
behaviors the respondent reports having been advised to do by his or her health care team. The authors 
of the scale present the normative data from seven different studies, demonstrating that the SDSCA has 
high inter-item correlations within scales (mean = 0.47), with the exception of specific diet.  Test-retest 
correlations are moderate (mean = 0.40). The SDSCA does not yield a total adherence score because 
previous research has shown that the different components of self-care treatment do not correlate 
highly with each other, and it is therefore necessary to assess each component separately (Johnson, 
1992). 
Marlowe-Crowne Social Desirability Scale. Because previous research has asserted that self-
report of adherence to recommended self-care behaviors may be influenced by socially desirability bias 
(Gordis, 1981), a short form version of the Marlowe-Crowne Social Desirability scale (John J. Ray, 
1984) was used to screen for socially desirable responding (see Appendix D). The measure has well 
documented validity and reliability (α’s = 0.74 to 0.77) (John J. Ray, 1981, 1984; J. J. Ray & Lovejoy, 
1984). 
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Interpersonal Support Evaluation Checklist (ISEL-12). Perceived availability of social 
resources was assessed using the short form of Cohen and colleagues’ Interpersonal Support 
Evaluation Checklist (Cohen & Hoberman, 1983; Cohen, Mermelstein, Kamarck, & Hoberman, 1985). 
The 12-item, self-report measure is a list of statements regarding available social support to which 
participants are asked to indicate whether each is “definitely true,” “probably true,” “probably false,” 
or “definitely false” (see Appendix E).  The standard form of the ISEL is 40 items and was designed to 
assess the perceived availability of four separate functions of social support: tangible, belonging, self-
esteem, and appraisal.  The brief, 12-item version was used in the present study, and it measures three 
of these functions: tangible, belonging, and appraisal.  The authors of the measure report that internal 
reliability ranged from α = .88 to .90 for the total score, and the ISEL-12 subscales range from α = .71 
to .84.   
Woodcock-Johnson III Oral Comprehension. The Oral Comprehension section of the 
Woodcock-Johnson III – Test of Achievement (Woodcock, McGrew, & Mather, 2001) was used to 
determine if participants have the ability to comprehend questions that will be read to them.  Oral 
comprehension is measured by the ability to comprehend a short passage and subsequently supply the 
missing word using syntactic and semantic cues. The test begins with simple analogies and 
associations and progresses to more complex passages. Oral Comprehension has a median reliability of 
.89 in adults. For the purposes of the present study, participants had to demonstrate at least a ninth 
grade oral comprehension level, as some of the other scales used have an approximate ninth grade 
reading level.  
Medical Chart Reviews. Study personnel conducted brief medical chart review to obtain 
ethnicity, diabetes and chronic illness status, HbA1c measurements, diabetes medications, and body 
mass index (BMI), calculated as weight in kilograms over height in meters squared (see Appendix F).   
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Procedure 
Data collection was conducted in the Medicine, Family Practice, and Foot Care clinics at Earl K. 
Long Medical Center. Patients with type 2 diabetes mellitus were recruited from the diabetes education 
classes, diabetes specialty clinic on Mondays at the Medicine Clinic, and waiting rooms at the 
respective clinics.  Patients who met inclusion and exclusion criteria were informed of the nature of the 
study, the time commitment, and compensation for study completion.  Interested participants were 
escorted to an exam room or more confidential area within the clinic and informed consent was 
obtained (see Appendix G), with a copy of the informed consent provided to each participant. 
Participants were instructed that the study aimed to examine the relationship between the 
environmental influences of social support and diabetes self-care.  Inclusion and exclusion criteria 
were discussed with participants and they were informed that if they fail to meet the inclusion criteria, 
their participation would be terminated. Study personnel also explained the limits of confidentiality to 
participants. They were asked if their medical chart could be reviewed for height, weight, HbA1c test 
results, and diabetes and chronic illness status. Participants consenting to this review signed an 
additional authorization form for the use and disclosure of protected health information for research 
purposes. Finally, participants were informed that they had the right to withdraw from the study at any 
time without affecting the healthcare they receive at Earl K. Long Medical Center. 
Following informed consent, participants were given a brief measure of oral comprehension to 
ensure that they are able to comprehend material at a ninth grade level.  Study personnel then 
completed the demographic questionnaire and measures of chronic illness resources and diabetes self-
care behaviors.  Due to the low literacy rate at this charity hospital, measures were read to the 
participants. All participants were given the contact information of the primary investigator for any 
questions or concerns that could arise following participation in the study. Participants were given 
ample time for questions regarding social support and diabetes self-care. Those patients who requested 
more information regarding specific diabetes self-management behaviors or treatment were referred to 
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one of two Certified Diabetes Educators at Earl K. Long. Participants were given a diabetes care 
incentive package (containing glucose tablets, Eucerin Intensive Repair® lotion samples, tissue packs, 
anti-bacterial hand wipes, and sugar-free candies) as compensation for participation in the study and 
escorted back to the clinic waiting room. The retail value of the packages was $5, commensurate with 
compensation offered by similar studies at this hospital. Finally, the primary investigator conducted a 
brief medical chart review to obtain ethnicity, gender, diabetes and chronic illness status, HbA1c 
measurements, diabetes medications, and body mass index (BMI), calculated as weight in kilograms 
over height in meters squared.  
HbA1c measures available within the four months prior to, or ordered at the visit of, each 
participant’s recruitment were obtained for statistical analyses. This time restriction was due to the 
nature of the self-report questionnaires being used, which asked respondents for their perceptions of 
social support within the past three months (Cohen & Hoberman, 1983; Cohen et al., 1985; Glasgow et 
al., 2000), and the reliability of HbA1c measures as a valid indicator of an individual’s glycemic 
control for only the past 3-4 months. 
Power Analyses 
Prior to the commencement of the study, power analyses were conducted in three steps, with 
alpha set at 0.05, 2-tailed for all analyses.  To analyze the effects of the set of seven predictor variables 
(i.e., environmental sources of support) on adherence to each of the five diabetes self-management 
behaviors and glycemic control, the current study estimated that the effect size of the ecological model 
would be large by Cohen’s convention, or d = .08 (R² = .14).  This effect size was chosen because it 
has been reported by the authors of the scale that the variance accounted for by the CIRS total score, in 
a study of dietary and physical activity intervention with female patients with diabetes, ranged from R² 
= .14 to .29 (Glasgow et al., 2005). This analysis yielded a sample size of 96 participants needed for an 
80% chance of detecting 14% of the variance predicted by the set of seven CIRS subscales.  
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Secondly, as the literature regarding the ecological theory of social support did not provide an 
empirical basis for the relationship of individual environmental sources on adherence or glycemic 
control, the current study aimed to determine if any of the seven predictor variables individually 
contributes significant, unique incremental variance.  This analysis yielded a sample size of 143 
participants needed for an 80% chance of detecting a unique incremental variance of % of any 
individual predictor variable in the regression model, holding constant the cumulative R² = .14 for the 
entire set of predictors.   
Lastly, analyses were conducted to determine the power needed for the hierarchical regression 
analyses to determine additional variance contributed by the CIRS in addition to that provided by the 
ISEL-12.  Previous social support research demonstrates that traditional models typically contribute a 
small to moderate amount (R² = .05) of variance in the prediction of adherence or HbA1c measures 
(Tillotson & Smith, 1996; Wang & Fenske, 1996), thus the current project would not assume that the 
cumulative variance supplied by the combination of all social support measures would yield larger than 
what is predicted in the simultaneous regression analyses, R² = .14.  The current study expected that 
the ISEL-12, entered in the first step of the regression model, would contribute R² = .05.  Therefore, a 
sample size of 146 participants would be necessary for an 80% chance of detecting 9% of additional 
variance explained by the CIRS, entered in the second step of the hierarchical regression model.  Due 
to the large number of predictor variables in the hierarchical regression model, there is not enough 
power to investigate individual contributions of the seven environmental sources. 
Given the power analysis results varied between N = 96-146, the sample size proposed for use 
in the current study is N = 150.  This criterion was met, and a total of 156 participants were used in the 
final analyses. 
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RESULTS 
Sample Characteristics and Descriptive Statistics 
One hundred fifty-nine patients were recruited for participation.  Three participants did not 
respond to questions after completing the informed consent, thus as no relevant data was available.  
These participants were excluded, and final analyses included 156 participants.  Sample characteristics 
are summarized in Tables 1 and 2. The sample was entirely African American, predominantly female 
(76%), low income (58% with a monthly household income < $1000), with a mean age of 52.8 years.  
Sixty-nine percent of the sample reported being not married, indicating their status as either single, 
divorced, or widowed. A majority of the sample (67.9%) reported not working, indicating their 
employment status as unemployed, retired, or disabled. 
Table 1 
Demographic Characteristics of Participants 
 M SD 
Age (years) 52.82 10.01 
Years of Education 11.67 1.97 
BMI 35.26 8.63 
 
Medical charts were reviewed for height, weight, diabetes diagnosis, current diabetes 
medications, and the presence of chronic disease and diabetes-related complications for all 
participants.  Health-related sample characteristics are summarized in Table 3. The average body mass 
index (BMI), calculated as weight in kilograms over height in meters squared, was 35.26 (SD = 8.63). 
BMI data was available for 152 participants. Individuals who were overweight (BMI between 25 and 
29.9) made up 19.1% of the sample and 70.4% were obese (BMI of 30 and higher).  All included 
participants carried a current diagnosis of diabetes mellitus type 2.  Almost all participants (96.2%) 
were receiving pharmacologic intervention as part of their diabetes care.  The sample had high rates of 
co-occurring chronic diseases, with 84.6% of the sample diagnosed with hypertension and 32.1% 
diagnosed with hyperlipidemia. 
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Table 2 
Sample Characteristics 
 N % 
Gender   
     Male 38 24.4% 
     Female 118 75.6% 
Marital Status   
     Single 68 43.6% 
     Married 39 25.0% 
     Separated 10 6.4% 
     Divorced 20 12.8% 
     Widowed 18 11.5% 
Monthly Household Income   
     < $1000 90 57.7% 
     $1000-$2000 59 37.8% 
     > $2000 7 4.5% 
Employment Status   
     Full-time 43 27.6% 
     Part-time 7 4.5% 
     Unemployed 43 27.6% 
     Retired 17 10.9% 
     Disabled 46 29.5% 
 
Table 3 
Health-Related Sample Characteristics 
 N % 
BMI Category   
     Underweight (<18.5) 0 0% 
     Normal (18.5-25) 16 10.5% 
     Overweight (25-30) 29 19.1% 
     Obese (>30) 107 70.4% 
Diabetes Medications   
     Pills Only 84 53.8% 
     Insulin Only 28 17.9% 
     Combination Therapy 38 24.4% 
     None 6 3.8% 
Medical Diagnoses   
     Chronic Renal Failure 5 3.2% 
     Congestive Heart Failure 8 5.1% 
     Coronary Artery Disease 12 7.7% 
     Hypertension 132 84.6% 
     Hyperlipidemia 50 32.1% 
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Missing Data 
 Twenty-five participants (15.9% of the sample) did not have a glycosylated hemoglobin (i.e., 
HbA1c) blood test resulted within the timeframe proposed at the outset of the study (120 days).  This 
percentage is very low, as anecdotal estimates from Earl K. Long diabetes clinic physicians estimated 
that as many as 60% of patients could have an outdated or missing test result.  Efforts were made to 
alert physicians to their patients’ consent to participate in the research study and the importance of a 
recent HbA1c value.  Small cards were given to consented participants to bring into their medical 
appointment (Appendix G).  Missing data was minimized on self-report measures because the 
questionnaires were administered orally by study personnel to all participants. 
 Expectation maximization (EM) methods were conducted using EQS 6.1 software 
(Mulitvariate Software, Inc.) to impute the missing values for HbA1c.  EM methods are especially 
effective for randomly missing data, when amounts of missing data are small (Tabachnick & Fidell, 
2007).  EM works by forming a covariance matrix with an assumed distribution for the partially 
missing data and “basing inferences about missing values on the likelihood under that distribution” 
(Tabachnick & Fidell, 2007).  This method was chosen to handle missing data because other methods 
(i.e., mean substitution, regression, casewise deletion) can significantly reduce variance and/or power.  
Furthermore, the amount of missing data imputed in the current study was small and no significant 
differences were apparent between the portions of the sample with and without valid HbA1c values on 
demographic indices (p > .05 for independent sample t-tests).   
 Missing data on all self-reported measures was negligible in all areas except for the work 
subscale of the CIRS.  Almost 70% of the study sample reported being unemployed, thus they did not 
complete items 58-64 of the CIRS (per questionnaire instructions). Thus, so few participants supplied 
useful data for this subscale that it was not used in analyses.   
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Correlations of Predictor and Criterion Variables 
 Preliminary analyses were conducted to determine if there were intercorrelations amongst the 
set of predictors (i.e., the six environmental resource subscales of the CIRS) and within the set of 
outcome variables (i.e., the five adherence behaviors and HbA1c values).  High correlations (R > 0.7) 
amongst the CIRS subscales could indicate a common factor of environmental support. Pearson r 
correlations are displayed in Table 4.  While scales were moderately correlated with each other, values  
were not high enough to suggest a single common factor, and it would be inappropriate to collapse the 
scales into one factor of environmental support, as consistent with previous literature (Glasgow et al.,  
2000). Correlations within the set of adherence behaviors and HbA1c values are displayed in Table 5.  
Consistent with previous literature that suggests these outcomes are independent and should be 
investigated separately (Johnson, 1992; Toljamo & Hentinen, 2001; Toobert et al., 2000), only 
minimal correlations were found.  No significant correlations were found between HbA1c and any 
adherence behavior. Also, no significant correlations were found between social desirability and the 
outcome variables. 
 Table 4 
Correlations of CIRS Subscales 
 Family/Friends Personal Neighborhood Media/Policy Organizations 
Physician/ 
Health Care Team 
.36* .27* .27* .20* .28* 
Family/Friends  .36* .51* .29* .35* 
Personal   .54* .38* .40* 
Neighborhood    .49* .54* 
Media/Policy     .46* 
* Correlation is significant at the 0.01 level (2-tailed). 
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Table 5 
Correlations of Adherence Behaviors and HbA1c 
 Specific Diet Glucose Test Physical 
Activity 
Medication 
Taking 
HbA1c 
General Diet 
 
.17* .15 .23* .22* -.03 
Specific Diet  .00 .05 .07 .05 
Glucose Test   -.03 -.01 .13 
Physical Activity    .21* .06 
Medication Taking     -.11 
* Correlation is significant at the 0.05 level (2-tailed) 
Intercorrelations of the predictor and criterion variables with demographic indices were also 
computed prior to regression calculations, as displayed in Tables 6 and 7.  Modest correlations were 
found between age and the CIRS personal subscale, general diet adherence, and medication taking.  A 
small negative correlation was found between age and HbA1c . Lastly, a modest correlation was found 
between reported years of education and the CIRS neighborhood/community subscale. 
Table 6 
Correlations of CIRS Subscales and Demographic Indices 
* Correlation is significant at the 0.01 level (2-tailed). 
 
 Age BMI Years of 
Education 
Gender 
Physician/Health 
Care Team 
.06 -.06 -.02 -.03 
Family/Friends .00 
 
.07 -.09 .03 
Personal .26* -.08 .02 -.14 
Neighborhood .09 -.06 -.21* -.06 
Media/Policy .08 -.09 -.02 -.03 
Organizations -.02 -.05 -.06 -.11 
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Table 7 
Correlations of Adherence Behaviors, HbA1c, and Demographic Indices 
 
* Correlation is significant at the 0.01 level (2-tailed). 
 
 
Primary Hypotheses 
Simultaneous multiple regression analyses were used to identify predictors of self-reported 
adherence to five diabetes self-care treatment behaviors (Hypothesis 1) and glycemic control 
(Hypothesis 2).  Six of the seven environmental social support sources of the Chronic Illness 
Resources Survey (i.e., personal, family and friends, physician/health care team, 
neighborhood/community, organizations, media and policy) were used as criterion variables.  Results 
of the regression for the prediction of adherence to self-care behaviors are summarized in Table 8.  R 
for regression was significantly different from zero for general diet [F(6,149) = 6.81, p < .01], specific 
diet [F(6,149) = 3.77, p < .01], blood glucose testing [F(6,149) = 5.70, p < .01], and medication taking 
[F(6,149) = 2.95, p < .01], but not physical activity. Results of regression for the prediction of 
glycemic control showed no significant values, F(6,149) = 1.31, p = .26. 
 Age BMI Years of 
Education 
Gender 
General Diet .29* -.05 .08 -.08 
Specific Diet .08 -.07 .13 .01 
Glucose Test .09 -.09 -.10 -.09 
Physical Activity 
 
.07 -.00 .06 -.16 
Medication .31* -.10 -.15 .11 
HbA1c -.19* .07 -.12 -.15 
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Table 8 
Hypothesis 1: Simultaneous Regression Analyses 
 R2 ß p 
General Diet .21**  .00 
 Physician  .23** .00 
 Family/Friends  -.09 .28 
 Personal  .35** .00 
 Neighborhood  -.08 .44 
 Media/Policy  .01 .90 
 Organizations  .12 .17 
Specific Diet .13**  .00 
 Physician  .26** .00 
 Family/Friends  .01 .89 
 Personal  .22* .02 
 Neighborhood  -.10 .38 
 Media/Policy  .08 .37 
 Organizations  -.06 .55 
Blood Glucose Testing .19**  .00 
 Physician  .00 .95 
 Family/Friends  -.07 .42 
 Personal  -.03 .70 
 Neighborhood  .34** .00 
 Media/Policy  .10 .27 
 Organizations  .12 .20 
Physical Activity .07  .10 
 Physician  .18 .04 
 Family/Friends  -.02 .83 
 Personal  .07 .49 
 Neighborhood  .08 .49 
 Media/Policy  .09 .33 
 Organizations  -.07 .50 
Medication Taking .11**  .01 
 Physician  .23** .01 
 Family/Friends  -.00 .98 
 Personal  .22* .02 
 Neighborhood  .01 .93 
 Media/Policy  -.04 .68 
 Organizations  -.06 .54 
* p < .05 
* p < .001 
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Inspection of R² indicates that the total model of the CIRS predicted approximately 18% of the 
variability within adherence to general diet (R² = .21, adjusted R² = .18). Further inspection of 
individual betas showed that this relationship was attributable to the physician/health care team (ß = 
.23, p < .01) and personal (ß = .35, p < .01) subscales, as no other subscales accounted for a significant 
portion of the variance.  R² = .13 for adherence to specific diet, with the adjusted R² = .10, indicating 
approximately 10% of the variability for this behavior attributable to the CIRS model.  Individual betas 
showed that this relationship was also attributable to the physician/health care team (ß = .26, p < .01) 
and personal (ß = .22, p < .05) subscales. The CIRS model predicted approximately 15% of the 
variance in adherence to blood glucose testing, (R² = .19, adjusted R² = .15), with the variability 
attributable to only the neighborhood/community subscale (ß = .34, p < .01).  Lastly, total model of the 
CIRS predicted approximately 7% of the variability within adherence to medication taking (R² = .11, 
adjusted R² = .07). Individual betas showed that this relationship was again attributable to the 
physician/health care team (ß = .23, p < .01) and personal (ß = .22, p < .05) subscales. 
Secondary Hypotheses 
The analyses proposed to test hypothesis 3, that the ecological model of social support would 
add additional variance beyond that explained by a traditional model of social support (i.e., ISEL-12), 
were hierarchical multiple regression analyses.  Intercorrelations of the ISEL-12 total score with the 
five adherence behaviors and glycemic control were conducted prior to regression calculations.  None 
of these correlations was significant, suggesting that the ISEL-12 would not be predictive of any 
variability in the outcome variables if entered into the first step of the hierarchical regressions.  
Hierarchical regressions, with ISEL-12 in the first step and the six CIRS subscales in the second step, 
were consistent with the correlation results.  In all regressions, the ISEL-12 scores were not significant, 
whereas the CIRS subscales did predict similar amounts of variance (accounting for the loss of an 
additional degree of freedom) as reported for hypotheses 1 and 2. 
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To test hypothesis 4, that the Chronic Illness Resources Survey will demonstrate comparable 
reliability and internal validity in the present sample to its previous use in a primarily Caucasian 
sample, Cronbach’s α was computed for the total scale.  Previous reports by the authors indicated α = 
.82 for the overall scale (Glasgow et al., 2000; Glasgow et al., 2005). Results of the present study 
indicated α = .73 for the overall scale, without the work subscale included.  The validity of the CIRS 
was explored through its factor structure.  Exploratory factor analysis with oblique rotation generated a 
six-factor structure corresponding to six subscales of personal, family and friends, physician/health 
care team, neighborhood/community, organizations, media and policy.  Almost all items loaded on the 
appropriate subscales, except for one item that loaded in another scale.  These analyses suggest that the 
CIRS demonstrated comparable reliability and internal validity in the low income, African American 
sample. 
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DISCUSSION 
The results of the present study support the use of the ecological model of social support as a 
predictor of adherence to self-management behaviors, but not glycemic control, in a sample of African 
American patients with type 2 diabetes mellitus.  Specifically, patients who indicated higher levels of 
support from their physician and health care team and from personal sources (e.g., self-reward, goal-
setting, prayer and meditation use) also reported greater levels of adherence to their general diet, 
specific diet, and medication-taking.  Patients who reported higher levels of support from their 
neighborhood and community also reported better adherence to the self-monitoring of blood glucose.  
These results are consistent with Glasgow’s assertions that social support influences originate from 
both institutional and interpersonal networks (Glasgow et al., 2000). The present study did not find an 
association between social support and adherence to regular physical activity or between social support 
and a target indicator of glycemic status (i.e., HbA1c tests). 
The current study attempted to assess the impact of environmental and community factors, 
beyond more traditional definitions of support from interpersonal networks, on diabetes self-
management.  While passive sources of support such as media, public policy, and organizations did not 
contribute to adherence, sources from both formal (institutional) and informal (interpersonal) networks 
were influential. The institutional network that attributed significant support in the current study was 
the physician and health care team.  Indeed, diabetes self-care is a multi-component regimen, and the 
American Diabetes Association (ADA, 2000) asserts guidelines for the use of a multi-disciplinary team 
to educate patients about the various components of their diabetes treatment plan, including the 
physician, registered nurse/Certified Diabetes Educator, registered dietician, behaviorist, and others. 
Furthermore, the treatment of diabetes as a chronic illness often requires regular medical visits and 
education classes for both the disease features and its complications, so the recommendations and 
advice of the medical team would be expected to be an integral part of a patient’s self-management. 
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Patients also indicate that personal sources of support are positively related to their adherence.  
The questions on this subscale of the CIRS specifically measure patients’ participation in rewarding 
their own positive behavior, goal-setting for diabetes management, the use of prayer and meditation, 
participation in positive activities, and time management.  One explanation of this finding could be that 
this subscale is assessing an underlying factor of self-efficacy for diabetes care. Thus, patients 
participating in supportive behaviors consistent with positive feelings of capability for self-care are 
also likely to be more adherent to their treatment.  Similarly, self-reported spirituality, religiosity, and 
participation in prayer has been previously shown to be positively related to disease adjustment and 
coping in a sample of African-American women with type 2 diabetes (Samuel-Hodge, et al., 2000).  
Previous research (Chin et al., 2004) has shown that in community health centers with similar 
populations to that used the current study, assessing for and including patients’ disease management 
goals in their medical records was a positive indicator of diabetes patient outcomes.  Items in the 
personal subscale of the CIRS assess not only the act of setting goals, but the review of disease 
management goals and self-reward for accomplishments.  These supportive behaviors are important for 
the encouragement of longer-term care, rather than short-term adherence.  This finding may suggest 
that participation in a supportive behavior like goal-setting, which encourages regular evaluation of 
treatment progress, is an important factor in the diabetes self-care regimen. Indeed, experts in the 
psychosocial factors of successful diabetes treatment currently call for public policy reform to include 
measures of patients’ disease management goals as part of standard diabetes care (Glasgow, et al. 
2002, 2007). 
Interestingly, social support was found to be predictive of several adherence behaviors but not 
glycemic control as measured by HbA1c. The diabetes self-management behaviors of focus in this 
study were selected because these were previously demonstrated to be most directly related to 
glycemic control (UKPDS, 1995, 1998a, 1998b). However, social support had no impact on patients’ 
measures of glycosolated hemoglobin. Several reasons are suggested for this finding.  First, the results 
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may be due to the nature of self-report utilized for measurement of both adherence behaviors and 
social support, despite the lack of demonstrated social desirability impact on these measures. 
As an outcome variable, HbA1c variance is typically limited, due to the nature of its 
measurement.  HbA1c measures reflect a time-weighted mean over the previous 120 days, and most 
accurately reflect the previous 3-4 months of metabolic control (Saudek et al., 2006). A reasonable 
target value for HbA1c is less than 7%, and the ADA recommends that therapy be reevaluated when 
HbA1c exceeds 8%. Thus, the expected variability of patients under treatment for diabetes mellitus 
should not be great.  Previous research has even suggested that HbA1c measures, although a gold 
standard for the stable and longer-term measurement of glycemic status, may be difficult for use in 
research because of its limited variability (Saudek et al., 2006). However, at the outset of the present 
study, anecdotal evidence regarding the variability of HbA1c measures in the study sample indicated 
that this would not be a limiting factor.  Indeed, the range of HbA1c measures used in the current study 
was 4.48% to 14.90%.  The mean was 8.5% (SD = 2.48), indicating that the sample participants’ 
average glycemic control was near the ADA recommended cut-offs. Despite preliminary attempts to 
transform variables to have distributions useful for analyses, the results using HbA1c as an outcome 
were not successful, indicating that other factors are likely contributing to the differing results. 
A final finding of the current study is that the Chronic Illness Resources Survey demonstrates 
comparable reliability and internal validity in this primarily low income, African American sample to 
its previous use in a primarily Caucasian sample.  Reliability for the six presently included subscales 
was measured to be similar to the previously reported measure for the total scale.  This value would 
likely be even more similar if the final subscale, sources of support in the work environment, was 
included.  Item loadings even further indicate the comparability of the scale, as out of fifty-seven 
items, only one loaded out of scale, yet not significantly enough to warrant further analyses.  Arguably, 
these results strengthen the interpretation of earlier findings based on the good psychometric properties 
of the scale used for measurement of the main construct. 
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The generalizability of these findings is affected by the limitations of the study design, 
particularly the use of self report measures and the small homogeneous sample.  Adherence to diabetes 
self-management behaviors was measured with a self-report questionnaire, the SDSCA.  While the 
SDSCA is the most widely used instrument for measuring diabetes self-management in adults, the use 
of self-report exclusively for these behaviors requires that the current findings be considered with 
caution.  The measurement of social support, using the CIRS, was also assessed via self-report.   
The sample was homogeneous as it consisted of only African American patients. The sample 
was also predominantly female and largely low income patients at a charity hospital in Southern 
Louisiana.  Recruitment was limited to only two outpatient clinics of the same hospital, and results 
may have differed if participants were recruited from other clinics or hospitals in the region.  
Furthermore, a majority of the study sample was overweight and obese, with a large proportion also 
having comorbid chronic illnesses.  This may limit generalizability of findings to only those patients 
whose illness status is more severe or are in need of seeking hospital services more readily.  This is 
also a sample of people shown to be generally physically inactive and not working, suggesting that our 
sample may simply have limited social contacts. Thus, participants may not have been able to 
accurately evaluate their levels of social support in areas outside of the home and medical settings. 
Despite these limitations, the results obtained in the current study indicate that environmental 
sources of social support are important factors in patients’ adherence to diabetes self-management 
behaviors.  The findings of the current study suggest the need for support from a multidisciplinary 
health care team and the setting and review of disease management goals as standards of care for 
effective diabetes treatment in a predominantly low income African American medical population.  
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Demographic Questionnaire 
 
EKL #: ______________________________ 
 
Date of Birth: ________________________  Age: _________________________ 
 
Height: ______________________________ Weight: _______________________ 
 
Marital Status (circle one):   
(1) single  (2) married  (3) separated     (4) divorced 
 
Years of Education: ____________________ 
 
Employment (circle one):   
(1) full-time     (2) part-time         (3) unemployed       (4) retired       (5) disabled 
 
Monthly household income (circle one):  
(1) < $1000  (2) $1000-2000 (3) >$2000 
 
Date diagnosed with diabetes: ______________________________ 
 
Age at diagnosis: __________________ 
 
Approximate duration of diabetes mellitus: _______________________ 
 
Diabetes medications: _____________________________________ 
 
   _____________________________________ 
 
   _____________________________________ 
 
   _____________________________________ 
 
 
Other illness diagnoses: ____________________________________ 
 
      ____________________________________ 
 
      ____________________________________ 
 
      ____________________________________ 
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Chronic Illness Resources Survey (CIRS) 
 
Managing a chronic illness (such as diabetes) can be time-consuming and challenging. It can involved taking medicine daily, 
exercising, following a specific diet, regular doctor visits, and coping with the impact of the illness upon you and those with whom 
you interact. The following questions ask about a variety of different resources that people may use to manage their illness. For each 
item, select the number that best indicates your experience over the past 3 months. 
 
Doctor and Health Care Team 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
1. Has your doctor, nurse, or dietitian clearly explained what you needed to do 
to manage your illness? 
1 2 3 4 5 
2. Has your doctor, nurse, or dietitian provided support between visits such as 
phone calls, reminder letters, or newsletters? 
1 2 3 4 5 
3. Has your doctor, nurse, or dietitian involved you as an equal partner in 
making decisions about illness management goals and strategies? 
1 2 3 4 5 
4. Has your doctor, nurse, or dietitian listened carefully to what you had to say 
about your illness? 
1 2 3 4 5 
5. Has your doctor, nurse, or dietitian answered your questions and addressed 
your concerns during office visits? 
1 2 3 4 5 
6. Has your doctor, nurse, or dietitian thoroughly explained the results of tests 
you had done (e.g., HbA1c, cholesterol, blood pressure, etc.)? 
1 2 3 4 5 
7. How important are your doctor, nurse, and dietitian resources to you in 
managing your illness? 
1 2 3 4 5 
 
Family and Friends 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
8. Have family or friends exercised with you? 1 2 3 4 5 
9. Have family or friends listened carefully to what you had to say about your 
illness? 
1 2 3 4 5 
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10. Have your family or friends encouraged you to do the things you needed to 
do for your illness? 
1 2 3 4 5 
11. Have family or friends selected or requested healthy food choices when you 
ate with them? 
1 2 3 4 5 
12. Have you shared healthy low-fat recipes with friends or family members? 1 2 3 4 5 
13. Have family or friends helped you to remember to take your medicine? 1 2 3 4 5 
14. Family or friends bought food or prepared food for you that were especially 
healthy or recommended? 
1 2 3 4 5 
15. How important is family and friend support in managing your illness? 1 2 3 4 5 
 
Personal (helpful thing you did for yourself) 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
16. Have you taken time for yourself to do things you enjoyed? 1 2 3 4 5 
17. Have your congratulated or rewarded yourself for the things you did to 
manage your illness? 
1 2 3 4 5 
18. Have you focused on the things you did well to manage your illness instead 
of those you did not? 
1 2 3 4 5 
19. Have you told others how they can help in managing your illness? 1 2 3 4 5 
20. Have you thought about or reviewed how you were doing in accomplishing 
your disease management goals? 
1 2 3 4 5 
21. Have you used prayer or meditation to provide guidance in managing your 
illness? 
1 2 3 4 5 
22. Have you arranged your schedule so that you could more easily do the things 
you needed to do for your illness? 
1 2 3 4 5 
23. How important are personal things, like those above, that you do for 
yourself, in managing your illness? 
1 2 3 4 5 
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Neighborhood 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
24. Have you walked or exercised outdoors in your neighborhood? 1 2 3 4 5 
25. Have you talked to neighbors or others who have experience living with a 
chronic illness? 
1 2 3 4 5 
26. Have you and your neighbors gotten together for activities such as barbecues, 
block, or holiday parties? 
1 2 3 4 5 
27. Have grocery stores where you shopped had a good supply of fresh fruits and 
vegetables? 
1 2 3 4 5 
28. Have you walked or done other exercise activities with neighbors? 1 2 3 4 5 
29. Have you shared recipes or discussed healthy eating ideas with neighbors? 1 2 3 4 5 
30. How important are neighborhood resources in managing your illness? 1 2 3 4 5 
 
Community 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
31. Have you gone to a pharmacy that had good information about your illness? 1 2 3 4 5 
32. Have you noticed healthy low-fat foods at stores where you frequently shop? 1 2 3 4 5 
33. Has your community made an effort to organize groups and organizations of 
people with chronic illness in civic activities? 
1 2 3 4 5 
34. Have you found that people in the community accepted you and others who 
have chronic illnesses? 
1 2 3 4 5 
35. Have you eaten at a restaurant that offered a variety of tasty, low-fat food 
choices? 
1 2 3 4 5 
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36. Have you used public transportation to get somewhere you were going? 1 2 3 4 5 
37. Have you gone to parks for picnics, walks, or other outings? 1 2 3 4 5 
38. How important is community environment to you in managing your illness? 1 2 3 4 5 
 
Media and Policy 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
39. Have you had health insurance that covered alternative therapies such as 
chiropractors and naturopaths? 
1 2 3 4 5 
40. Have you read articles in newspapers or magazines about people who were 
successfully managing a chronic illness? 
1 2 3 4 5 
41. Have you had health insurance that covered most of the costs of your medical 
needs including medicine? 
1 2 3 4 5 
42. Have you seen billboards or other advertisements that encouraged not 
smoking, low-fat eating, or regular exercise? 
1 2 3 4 5 
43. Have you listed to television or radio programs that focused on health or 
lifestyle issues? 
1 2 3 4 5 
44. Have you heard things on the news that encouraged you to take good care of 
your health? 
1 2 3 4 5 
45. Have you used the Internet or World Wide Web to share information about 
your illness? 
1 2 3 4 5 
46. Have you seen TV programs or heard radio programs that realistically 
portrayed what it’s like living with a chronic illness? 
1 2 3 4 5 
47. Have you seen TV programs or heard radio programs that provided good 
information on your illness? 
1 2 3 4 5 
48. How important are media and policy resources (like those above) to you in 
managing your illness? 
1 2 3 4 5 
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Community Organizations 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
49. Have you called a national or local health organization for information about 
your illness (such as an 800 number)? 
1 2 3 4 5 
50. Have people at your church (or other organization to which you belong) 
shown understanding and support for your illness management efforts? 
1 2 3 4 5 
51. Have you participated in walks or other activities for health organizations 
(such as Heart, Lung, or Diabetes associations)? 
1 2 3 4 5 
52. Have you attended free or low-cost meetings (for example, Weight Watchers, 
church groups, hospital programs) that supported you in managing your 
illness? 
1 2 3 4 5 
53. Have you volunteered your time for local organizations or causes? 1 2 3 4 5 
54. Have you attended wellness programs or fitness facilities? 1 2 3 4 5 
55. Have you called or visited a local health organization or hospital to look up 
information, view a video, or check out written materials? 
1 2 3 4 5 
56. Have you used community resources to help manage your illness such as 
senior centers, community centers, or mall walking programs? 
1 2 3 4 5 
57. How important are community and health organizations (church, etc.) to you 
in managing your illness? 
1 2 3 4 5 
 
Work (If not currently employed, please skip items 58-64) 
  
Over the past 3 months, to what extent: 
Not at all A little A 
moderate 
amount 
Quite a 
bit 
A great 
deal 
58. Have you had a flexible work schedule that you could adjust to meet your 
needs? 
1 2 3 4 5 
59. Has your work offered wellness programs or fitness facilities? 1 2 3 4 5 
60. Has your workplace had rules or policies that made it easier for you to 
manage your illness (such as no smoking rules or time off work to exercise)? 
1 2 3 4 5 
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61. Have your coworkers covered for you when you needed to do something to 
manage your illness or where not feeling well? 
1 2 3 4 5 
62. Have you had control over your job in terms of making decisions and setting 
priorities? 
1 2 3 4 5 
63. Has your employer paid time off work for health care or fitness activities? 1 2 3 4 5 
64. How important are worksite support and resources to you in managing your 
illness? 
1 2 3 4 5 
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APPENDIX C 
 
SUMMARY OF DIABETES SELF-CARE ACTIVITIES MEASURE 
52 
The Summary of Diabetes Self-Care Activities 
 
Instructions: The questions below ask you about your diabetes self-care activities during the past 7 
days. If you were sick during the past 7 days, please think back to the last 7 days that you were not 
sick. 
 
Diet 
1. How many of the last SEVEN DAYS have you followed a 
healthful eating plan? 
 
0 1 2 3 4 5 6 7 
2. On average, over the past month, how many DAYS PER 
WEEK have you followed your eating plan? 
0 1 2 3 4 5 6 7 
3. On how many of the last SEVEN DAYS did you eat five or 
more servings of fruits and vegetables? 
0 1 2 3 4 5 6 7 
4. On how many of the last SEVEN DAYS did you eat high 
fat foods such as red meat or full-fat dairy products? 
0 1 2 3 4 5 6 7 
 
Exercise 
5. On how many of the last SEVEN DAYS did you 
participate in at least 30 minutes of physical activity? 
(Total minutes of continuous activity, including walking) 
0 1 2 3 4 5 6 7 
6. On how many of the last SEVEN DAYS did you 
participate in a specific exercise session (such as 
swimming, walking, biking) other than what you do around 
the house or as part of your work? 
0 1 2 3 4 5 6 7 
 
Blood Sugar Testing 
7. On how many of the last SEVEN DAYS did you test your 
blood sugar? 
0 1 2 3 4 5 6 7 
8. On how many of the last SEVEN DAYS did you test your 
blood sugar the number of times recommended by your 
health care provider? 
0 1 2 3 4 5 6 7 
 
Medications 
9. On how many of the last SEVEN DAYS did you take your 
recommended diabetes medications?  
0 1 2 3 4 5 6 7 
10. On how many of the last SEVEN DAYS did you take your 
recommended insulin injections? 
0 1 2 3 4 5 6 7 
11. On how many of the last SEVEN DAYS did you take your 
recommended number of diabetes pills? 
0 1 2 3 4 5 6 7 
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APPENDIX D 
 
MARLOWE-CROWNE SOCIAL DESIRABILITY SCALE 
54 
Marlowe-Crowne Scale 
Instructions: For each of the following questions, please circle “Yes”, “No”, or “Not Sure”.  
1. Have there been occasions when you took advantage of 
someone? 
 
Yes No Not Sure 
2. Have you sometimes taken unfair advantage of another 
person? 
Yes No Not Sure 
3. Are you always willing to admit when you make a mistake? Yes No Not Sure 
4. Are you quick to admit making a mistake? Yes No Not Sure 
5. Do you sometimes try to get even rather than forgive and 
forget? 
Yes No Not Sure 
6. Do you sometimes feel resentful when you don’t get your 
own way? 
Yes No Not Sure 
7. Are you always courteous, even to people who are 
disagreeable? 
Yes No Not Sure 
8. Are you always a good listener, no matter whom you are 
talking to? 
Yes No Not Sure 
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APPENDIX E 
 
INTERPERSONAL SUPPORT EVALUATION CHECKLIST 
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ISEL-12 
 
Instructions: This scale is made up of a list of statements each of which may or may not be true about you. For each statement, circle 
"definitely true" if you are sure it is true about you and "probably true" if you think it is true but are not absolutely certain. You should 
circle "definitely false" if you are sure the statement is false and "probably false" if you think it is false but are not absolutely certain.  
 
  
 
Definitely 
False 
Probably 
False 
Probably 
True 
Definitel
y True 
1. If I wanted to go on a trip for a day, I would have a hard time finding someone to 
go with me. 
1 2 3 4 
2. I feel that there is no one I can share my most private worries and fears with. 1 2 3 4 
3. If I were sick, I could easily find someone to help me with my daily chores. 1 2 3 4 
4. There is someone I can turn to for advice about handling problems with my 
family. 
1 2 3 4 
5. If I decide one afternoon that I would like to go to a movie that evening, I could 
easily find someone to go with me. 
1 2 3 4 
6. When I need suggestions on how to deal with a personal problem, I know 
someone I can turn to. 
1 2 3 4 
7. I don't often get invited to do things with others. 1 2 3 4 
8. If I had to go out of town for a few weeks, it would be difficult to find someone 
who would look after my house or apartment (the plants, pets, garden, etc.). 
1 2 3 4 
9. If I wanted to have lunch with someone, I could easily find someone to join me. 1 2 3 4 
10. If I was stranded 10 miles from home, there is someone I could call who could 
come and get me. 
1 2 3 4 
11. If a family crisis arose, it would be difficult to find someone who could give me 
good advice about how to handle it. 
1 2 3 4 
12. If I needed some help in moving to a new house or apartment, I would have a hard 
time finding someone to help me. 
1 2 3 4 
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APPENDIX F 
 
MEDICAL CHART REVIEW FORM 
58 
Medical Chart Review Form 
 
EKL #: ______________________________   Diabetes Mellitus Type:      I         II 
 
Date of Recruitment: ___________________            Date Valid HbA1c: ___________________  
 
Date of Birth: _________________________  Age: _________________________ 
 
Height: ___________  Weight: ___________  Date Taken: ___________________ 
 
HbA1c Measures  Date Taken  HbA1c Measures  Date Taken 
 
____________________________________ ____________________________________ 
 
____________________________________ ____________________________________ 
 
____________________________________ ____________________________________ 
 
 
Diabetes medications: 
Sulfonylureas Rapid-Acting Insulin 
   ? Amaryl (Glimepiride)    ? Humalog (Lispro) 
   ? DiaBeta, Glynase, or Micronase (Glyburide)    ? Novolog (Aspart) – injections or pen 
   ? Glucotrol – regular, XL, or ER (Glipizide)  
 Short-Acting Insulin 
Biguanides    ? Humulin or Novolin R 
   ? Glucophage or Glucophage XR (Metformin)  
 Intermediate-Acting Insulin 
Thiazolidinediones    ? Humulin or Novolin N (NPH) 
   ? Actos (Pioglitazone)    ? Novolin or Novolin L 
   ? Avandia (Rosiglitazone)  
 Long-Acting Insulin 
Alpha-glucosidase inhibitors    ? Ultralente (Humulin U) 
   ? Glyset (Meglitol)    ? Lantus (Glargine) 
   ? Precose (Acarbose)  
 Premixed Insulin 
Oral combination therapy     ? Humalog 75/25 mix
   ? Avandamet (Rosiglitazone-Metformin)    ? Humulin 70/30 mix 
   ? Glucovance (Glyburide-Metformin)    ? Novolin 70/30 mix 
    ? Novolog 70/30 mix 
 
Other illness diagnoses/complications:   
? chronic renal failure    ? retinopathy 
? congestive heart failure    ? neuropathy 
? coronary artery disease    ? amputation 
? hypertension     ? history of heart attack/stroke 
? hyperlipidemia     ? other: ____________________________ 
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APPENDIX G 
 
INFORMED CONSENT 
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LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER IN NEW ORLEANS: 
INFORMED CONSENT FORM 
 
1.  STUDY TITLE:   
Environmental Influences on Adherence to Self-Management Behaviors and Glycemic Control in 
African American Patients with Type 2 Diabetes Mellitus  
 
2.  PERFORMANCE SITES: 
Earl K. Long Medical Center, Baton Rouge, LA 
 
3.  NAMES AND TELEPHONE NUMBERS OF INVESTIGATORS: 
Principle Investigator:   Phillip J. Brantley, Ph.D. (225) 763-3046 
Co-Investigators:  Jolene Johnson, M.D.  (225) 358-1311 
Brooke L. Barbera, B.A. (225) 358-1105 
 
4.  PURPOSE OF THE STUDY: 
The purpose of the study is to better understand the type of social support African American patients 
with type 2 diabetes mellitus receive from their family, friends, health care team, community, 
neighborhood, work place, and others.  This study is interested in understanding how this self-reported 
social support is related to participants’ adherence to self-management treatment behaviors (i.e., diet, 
physical activity, medication-taking, and blood glucose monitoring) and glycemic control. 
 
5.  DESCRIPTION OF THE STUDY: 
Dr. Brantley will be directing this study. Dr. Johnson will also be providing medical supervision. 
The researchers of this study will recruit approximately 250 patients with type 2 diabetes mellitus over 
the age of 18 at the medicine clinics of Earl K. Long Medical Center. Study personnel will identify 
potential participants prior to their scheduled medical appointments and/or class meetings.  If you meet 
inclusion criteria listed above and agree to participate, you can expect the following to occur during the 
course of this study: 
• All questionnaires will be read to you.  You will complete the questionnaires in an exam room 
or confidential area of the clinic, with a research assistant. 
• The first measure is a brief questionnaire to ensure that you can understand the questions you 
will be asked and the additional questionnaires that will be read to you. 
• The remaining measures will be a demographic questionnaire and measures of your social 
resources related to your diabetes care. 
• You will be given enough time to ask questions about social support and/or your diabetes self-
care. If you request more information regarding your specific diabetic treatment regimen, you 
will be referred to your physician or a Certified Diabetes Educator at Earl K. Long. 
• Study personnel will conduct a brief review of your medical chart to obtain diabetic and 
chronic illness status, HbA1c measurements, names of diabetic medications, height and weight. 
• Your participation in this study takes place at the time of your visit only, and there will be no 
follow-up after you complete the questionnaires.   
• You will be paid five dollars for your participation in this study. 
 
6.  BENEFITS TO SUBJECT: 
We cannot promise any benefits from your being in the study.  However, possible benefits include 
achieving a better understanding of the factors related to your diabetes care. 
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7.  RISKS TO SUBJECT: 
There is an emotional risk for participants in this study.  It is possible for some participants to 
become distressed by the self-realization of unsafe health behaviors.  If you should become distressed 
while filling out the questionnaires, please tell the research assistant or contact the investigators of the 
study as listed on this form.  You will be given a referral to the Adult Psychology department at Earl 
K. Long Medical Center.  
There is also a mild risk to confidentiality.  Every attempt will be made to protect your 
confidentiality (e.g., you will complete the study in an examination room, only individuals involved 
with the study will have access to collected data, all data spreadsheets will be kept on a password 
protected file, all patient information will be kept in a locked room in the Adult Clinical 
Psychology/Raymond Potter Building, and all references to participants’ names will be destroyed after 
publishing the study). 
 
8.  ALTERNATIVES TO PARTICIPATION IN THE STUDY: 
You have the choice at any time not to participate in this research study.  If you choose not to 
participate, you may stop at any time without consequence, and your medical care will not be affected 
or disrupted. 
 
9.  SUBJECT REMOVAL: 
There are no circumstances for which a participant would be removed.    
 
10.  SUBJECT’S RIGHT TO REFUSE TO PARTICIPATE OR WITHDRAW: 
Participation is voluntary.  Refusal to participate will involve no penalty or loss of benefits to which 
the participant is otherwise entitled, and you may discontinue participation at any time without penalty 
or loss of benefits to which you are otherwise entitled.  Should significant new findings develop during 
the course of the research, which may relate to your willingness to continue participation, that 
information will be provided to you. 
 
11.  SUBJECT’S RIGHT TO PRIVACY/HEALTH INSURANCE PORTABILITY AND 
ACCOUNTABILITY ACT (HIPPA) 
Records that you give us permission to keep and that identify you, will be kept as confidential as 
required by law.  Federal Privacy Regulations provide safeguards for privacy, security, and authorized 
access.  The results of this study may be published.  The privacy of participants will be protected and 
participants will not be identified in any way in published results.  The research team will make every 
effort to keep your information confidential.  For example, your identity will be kept confidential by 
not writing your name on any of the materials, destroying all references to participants’ names after 
publishing the study, and not allowing access to data by any persons other than those running the 
study. 
 
 
12.  RELEASE OF INFORMATION 
The medical records related to the study are available to the LSUHSC IRB.  While every effort will be 
made to maintain privacy, absolute confidentiality cannot be guaranteed.  Records will be kept private 
to the extent allowed by law. 
 
13.  FINANCIAL INFORMATION: 
 A) There will be $5 payment for participating in this study. 
B)  There will be no costs for participating in this study. 
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14.  SIGNATURES: 
This study has been discussed with me and all of my questions have been answered. Additional 
questions regarding the study should be directed to investigators listed on the first page of this consent 
form.  If I have questions about participants’ rights, or other concerns, I can contact the Chancellor of 
LSU Health Sciences Center at (504) 568-4801.  I agree with the terms above, acknowledge I have 
been given a copy of the consent form, and agree to participate in this study.  I understand that I have 
not waived any of my legal rights by signing this form. 
 
_____________________________________________________________________________ 
Signature of the Subject       Date 
 
_____________________________________________________________________________ 
Signature of the Witness       Date 
 
 
The study subject has indicated to me that the subject is unable to read.  I certify that I have read this 
consent form to the subject and explained that by completing the signature line above the subject has 
agreed to participate. 
 
_____________________________________________________________________________ 
Signature of the Reader       Date 
 
_____________________________________________________________________________ 
Signature of the Person Administering Consent    Date 
 
_____________________________________________________________________________ 
Signature of the Principle Investigator     Date 
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